Michelle Rampersad
Oncology · Sebring, FLNPI 1518154236
Payments from drug & device makers
$34,018in general payments, 2019–2025
Across 582 payments — averaging $58.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$23K
- Johnson & Johnson$1K
- Novartis$1K
- AstraZeneca$839
- Astellas Pharma US Inc$567
- Lilly USA, LLC$552
- plus $6K from 54 others
General payments by program year
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$34,018 in reported general payments places this provider in the 95th percentile of 24 oncology providers in Florida.
Other oncology in Sebring
- Sara BeelerTampa$337K
- Janell VerkadenOrmond Beach$19K
- Kimberly TopeTampa$16K
- Aaron DohenySt Petersburg$14K
- Naima Vera-SommersTampa$11K
- Amber AlbaughLecanto$9K
- Natalie GessnerClearwater$8K
- Melissa BlandfordHudson$6K
- Glenda KaminskiLakeland$5K
- Lee PavelBonita Springs$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.